← Leaderboards
Michael Stephen Glickman
Sloan-Kettering Inst Can Research
$43,477,930
Attributed
$70,665,461
Total exposure
21
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$132,311,605 · 23
By mechanism
U19$110,388,934 · 16
R01$19,785,345 · 5
P50$1,763,430 · 1
K08$373,896 · 1
Top collaborators
- Carl F Nathan25 shared
- Sabine Ehrt13 shared
- Daniel W Fitzgerald8 shared
- Jeffrey Aube7 shared
- Jean-Laurent Casanova7 shared
- Veronique Dartois7 shared
- Michael Haggai Glickman7 shared
- Kyu Y Rhee7 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Scott W Lowe$63,222,126
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisInfectionPathway InteractionsGeneticIn VivoMouse ModelIn VitroPharmaceutical PreparationsPathogenInsightMolecularPathogenesisMutantBaseResponseHaitiRelapseGrowthBacteriaFamilyPhenotypeGenus MycobacteriumMycobacterial
Grant awards (133)
Determinants of TB control, relapse and reinfection$2,329,771
U19 · FY2025 · AI
Determinants of TB control, relapse and reinfection$203,405
U19 · FY2025 · AI
Determinants of TB control, relapse and reinfection$2,583,036
U19 · FY2024 · AI
Mycobacterial DNA repair and mutagenesis$663,906
R01 · FY2024 · AI · contact PI
Determinants of TB control, relapse and reinfection$2,565,026
U19 · FY2023 · AI
Mycobacterial DNA repair and mutagenesis$663,906
R01 · FY2023 · AI · contact PI
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis$463,302
R01 · FY2023 · AI · contact PI
Determinants of TB control, relapse and reinfection$2,583,322
U19 · FY2022 · AI
Mycobacterial DNA repair and mutagenesis$663,906
R01 · FY2022 · AI · contact PI
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis$463,302
R01 · FY2022 · AI · contact PI
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer$343,314
P50 · FY2022 · CA · contact PI
Determinants of TB control, relapse and reinfection$2,755,450
U19 · FY2021 · AI
Mycobacterial DNA repair and mutagenesis$663,906
R01 · FY2021 · AI · contact PI
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis$463,302
R01 · FY2021 · AI · contact PI
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer$351,268
P50 · FY2021 · CA · contact PI
Tri-Institutional TB Research Unit: Persistence and Latency$6,446,187
U19 · FY2020 · AI
Viable but Nonculturable Mtb$947,618
U19 · FY2020 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection$866,176
U19 · FY2020 · AI
Clinical Core$864,157
U19 · FY2020 · AI
Mouse models for paucibacillary persistence$802,328
U19 · FY2020 · AI
Chemistry Core$766,342
U19 · FY2020 · AI
Mycobacterial DNA repair and mutagenesis$663,906
R01 · FY2020 · AI · contact PI
Epidemiology of SARS-CoV-2 in Low-income Countries.$632,901
U19 · FY2020 · AI
Clinical Core$632,901
U19 · FY2020 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis$610,909
U19 · FY2020 · AI
Pharmacology$601,886
U19 · FY2020 · AI
Administrative Core$537,471
U19 · FY2020 · AI
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis$463,302
R01 · FY2020 · AI · contact PI
Biomarkers of PZA activity and it's target populations$449,300
U19 · FY2020 · AI
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer$356,379
P50 · FY2020 · CA · contact PI
Epidemiology of SARS-CoV-2 in Low-income Countries.$353,106
U19 · FY2020 · AI
Tri-Institutional TB Research Unit: Persistence and Latency$6,756,890
U19 · FY2019 · AI
Viable but Nonculturable Mtb$1,436,684
U19 · FY2019 · AI
Mouse models for paucibacillary persistence$1,053,123
U19 · FY2019 · AI
Clinical Core$1,015,476
U19 · FY2019 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection$644,317
U19 · FY2019 · AI
Chemistry Core$632,917
U19 · FY2019 · AI
Administrative Core$605,886
U19 · FY2019 · AI
Biomarkers of PZA activity and it's target populations$593,265
U19 · FY2019 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis$549,818
R01 · FY2019 · AI · contact PI
Pharmacology$501,029
U19 · FY2019 · AI
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis$463,302
R01 · FY2019 · AI · contact PI
Human Genetic Dissection of Exit from Latency in Tuberculosis$355,865
U19 · FY2019 · AI
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer$343,314
P50 · FY2019 · CA · contact PI
Tri-Institutional TB Research Unit: Persistence and Latency$6,663,767
U19 · FY2018 · AI
Viable but Nonculturable Mtb$1,277,246
U19 · FY2018 · AI
Mouse models for paucibacillary persistence$1,044,526
U19 · FY2018 · AI
Clinical Core$990,212
U19 · FY2018 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection$898,096
U19 · FY2018 · AI
Biomarkers of PZA activity and it's target populations$629,784
U19 · FY2018 · AI
Chemistry Core$613,104
U19 · FY2018 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis$549,818
R01 · FY2018 · AI · contact PI
Administrative Core$507,593
U19 · FY2018 · AI
Pharmacology$485,623
U19 · FY2018 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis$457,452
U19 · FY2018 · AI
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer$369,155
P50 · FY2018 · CA · contact PI
Viable but Nonculturable Mtb$118,513
U19 · FY2018 · AI
Tri-Institutional TB Research Unit: Persistence and Latency$118,513
U19 · FY2018 · AI
Tri-Institutional TB Research Unit: Persistence and Latency$6,990,368
U19 · FY2017 · AI
Viable but Nonculturable Mtb$1,246,465
U19 · FY2017 · AI
Mouse models for paucibacillary persistence$1,031,737
U19 · FY2017 · AI
Clinical Core$988,221
U19 · FY2017 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection$946,851
U19 · FY2017 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis$683,161
U19 · FY2017 · AI
Chemistry Core$620,478
U19 · FY2017 · AI
Biomarkers of PZA activity and it's target populations$619,307
U19 · FY2017 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis$549,818
R01 · FY2017 · AI · contact PI
Administrative Core$510,529
U19 · FY2017 · AI
Pharmacology$491,841
U19 · FY2017 · AI
Tri-Institutional TB Research Unit: Persistence and Latency$7,215,105
U19 · FY2016 · AI
Viable but Nonculturable Mtb$1,337,354
U19 · FY2016 · AI
Mouse models for paucibacillary persistence$1,123,169
U19 · FY2016 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection$880,842
U19 · FY2016 · AI
Clinical Core$877,948
U19 · FY2016 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis$869,244
U19 · FY2016 · AI
Biomarkers of PZA activity and it's target populations$661,554
U19 · FY2016 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis$549,818
R01 · FY2016 · AI · contact PI
Administrative Core$530,864
U19 · FY2016 · AI
Chemistry Core$526,905
U19 · FY2016 · AI
Pharmacology$407,224
U19 · FY2016 · AI
Tri-Institutional TB Research Unit: Persistence and Latency$7,165,182
U19 · FY2015 · AI
Viable but Nonculturable Mtb$1,581,787
U19 · FY2015 · AI
Mouse models for paucibacillary persistence$1,061,923
U19 · FY2015 · AI
Clinical Core$936,892
U19 · FY2015 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection$645,460
U19 · FY2015 · AI
Biomarkers of PZA activity and it's target populations$645,217
U19 · FY2015 · AI
Chemistry Core$632,183
U19 · FY2015 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis$619,274
U19 · FY2015 · AI
Administrative Core$559,889
U19 · FY2015 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis$549,818
R01 · FY2015 · AI · contact PI
Pharmacology$482,557
U19 · FY2015 · AI
Tri-Institutional TB Research Unit: Persistence and Latency$6,284,115
U19 · FY2014 · AI
Mouse models for paucibacillary persistence$879,783
U19 · FY2014 · AI
Viable but Nonculturable Mtb$876,100
U19 · FY2014 · AI
Clinical Core$850,199
U19 · FY2014 · AI
Chemistry Core$813,391
U19 · FY2014 · AI
Innate, Transcriptomic, and Microbiomic correlates of TB infection$726,216
U19 · FY2014 · AI
Pharmacology$624,658
U19 · FY2014 · AI
Administrative Core$595,212
U19 · FY2014 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis$468,805
U19 · FY2014 · AI
Biomarkers of PZA activity and it's target populations$449,751
U19 · FY2014 · AI
Molecular analysis of mycobacterial NHEJ$497,253
R01 · FY2013 · AI · contact PI
CD4 T Cell Responses to M. Tuberculosis Infection$437,385
R01 · FY2013 · AI
Molecular analysis of mycobacterial NHEJ$528,992
R01 · FY2012 · AI · contact PI
Cyclopropane Synthetases and M.tuberculosis Pathogenesis$465,302
R01 · FY2012 · AI · contact PI
CD4 T Cell Responses to M. Tuberculosis Infection$465,302
R01 · FY2012 · AI
Molecular analysis of mycobacterial NHEJ$527,774
R01 · FY2011 · AI · contact PI
CD4 T Cell Responses to M. Tuberculosis Infection$465,302
R01 · FY2011 · AI
Cyclopropane Synthetases and M.tuberculosis Pathogenesis$465,302
R01 · FY2011 · AI · contact PI
Molecular analysis of mycobacterial NHEJ$532,706
R01 · FY2010 · AI · contact PI
Molecular Analysis of the Rip1 Virulence Pathway of M. tuberculosis$474,750
R01 · FY2010 · AI · contact PI
Cyclopropane Synthetases and M.tuberculosis Pathogenesis$470,003
R01 · FY2010 · AI · contact PI
CD4 T Cell Responses to M. Tuberculosis Infection$470,003
R01 · FY2010 · AI
CD4 T Cell Responses to M. Tuberculosis Infection$474,750
R01 · FY2009 · AI
Cyclopropane Synthetases and M.tuberculosis Pathogenesis$474,750
R01 · FY2009 · AI · contact PI
Molecular Analysis of the Rip1 Virulence Pathway of M. tuberculosis$467,558
R01 · FY2009 · AI · contact PI
DNA Ligases in Mycobacterial DNA repair & Pathogenesis$424,620
R01 · FY2009 · AI · contact PI
Cyclopropane Synthetases and M.tuberculosis Pathogenesis$15,168
R01 · FY2009 · AI · contact PI
DNA Ligases in Mycobacterial DNA repair & Pathogenesis$5,963
R01 · FY2009 · AI · contact PI
Cyclopropane Synthetases and M.tuberculosis Pathogenesis$474,750
R01 · FY2008 · AI · contact PI
DNA Ligases in Mycobacterial DNA repair & Pathogenesis$424,620
R01 · FY2008 · AI · contact PI
DNA Ligases in Mycobacterial DNA repair & Pathogenesis$432,844
R01 · FY2007 · AI · contact PI
Cyclopropane Synthetases and M.tuerculosis Virulence$338,145
R01 · FY2007 · AI · contact PI
DNA Ligases in Mycobacterial DNA repair & Pathogenesis$408,665
R01 · FY2006 · AI · contact PI
Cyclopropane Synthetases and M.tuerculosis Virulence$348,245
R01 · FY2006 · AI · contact PI
DNA Ligases in Mycobacterial DNA repair &Pathogenesis$418,500
R01 · FY2005 · AI
Cyclopropane Synthetases and M.tuerculosis Virulence$356,625
R01 · FY2005 · AI
Cyclopropane Synthetases and M.tuerculosis Virulence$356,625
R01 · FY2004 · AI
Cyclopropane Synthetases and M. tuberculosis Virulence$178,313
R01 · FY2003 · AI
CELL ENVELOPE BIOSYNTHESIS IN M TUBERCULOSIS$121,716
K08 · FY2002 · AI
CELL ENVELOPE BIOSYNTHESIS IN M TUBERCULOSIS$95,040
K08 · FY2001 · AI
CELL ENVELOPE BIOSYNTHESIS IN M TUBERCULOSIS$31,050
K08 · FY2001 · AI
CELL ENVELOPE BIOSYNTHESIS IN M TUBERCULOSIS$126,090
K08 · FY2000 · AI